This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Tetrafluoroborate
- DrugBank Accession Number
- DB16340
- Background
Tetrafluoroborate is under investigation in clinical trial NCT02907073 (Positron Emission Tomography (PET) Imaging Studies With NIS Reporter).
- Type
- Small Molecule
- Groups
- Investigational
- Structure
Structure for Tetrafluoroborate (DB16340)
- Weight
- Average: 86.8
Monoisotopic: 87.003466 - Chemical Formula
- BF4
- Synonyms
- Borate(1-), tetrafluoro-
- Fluoroborate
- Tetrafluoroborate
- Tetrafluoroborate (bf41-)
- Tetrafluoroborate anion
- Tetrafluoroborate ion
- Tetrafluoroborate(1-)
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 4YCF3545OY
- CAS number
- 14874-70-5
- InChI Key
- ODGCEQLVLXJUCC-UHFFFAOYSA-N
- InChI
- InChI=1S/BF4/c2-1(3,4)5/q-1
- IUPAC Name
- tetrafluoroboranuide
- SMILES
- F[B-](F)(F)F
References
- General References
- Not Available
- External Links
- ChemSpider
- 24463
- BindingDB
- 26993
- ChEBI
- 38899
- ChEMBL
- CHEMBL1789400
- ZINC
- ZINC000242581732
- Wikipedia
- Tetrafluoroborate
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 1, 2 Terminated Diagnostic Endometrial Cancer / Multiple Myeloma (MM) 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP -1.1 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 0 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 6.01 m3·mol-1 Chemaxon Polarizability 3.55 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at December 15, 2020 20:02 / Updated at December 20, 2020 03:41